BackSynaptogenix Overview

Synaptogenix Current Cash

Synaptogenix's current cash is $3.6M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$3.65M
↓ 75.42% YoYΔ $-11.19M vs prior year quarter

Peer average

Loading

Synaptogenix Current Cash History

Loading

Synaptogenix vs. peers: Current Cash Comparison

Loading

Synaptogenix Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Synaptogenix (SNPX) FAQ

Synaptogenix (SNPX) currently reports a current cash of $3.6M as of March 2026. That compares with $15M in the prior-year period — down 75.4% year over year. Use the charts on this page to explore Synaptogenix's current cash history and peer comparisons.

Synaptogenix's current cash decreased from $15M to $3.6M — a 75.4% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Synaptogenix reported $3.6M in current cash as of March 2026. That compares with $15M in the prior-year period — down 75.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $3.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Synaptogenix, and consider following SNPX for alerts when major investors trade the stock.

Synaptogenix is classified in the Healthcare sector. On current cash, it currently shows $3.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNPX with unrelated industries.